Publicaciones en colaboración con investigadores/as de Institute of Oncology Ljubljana (11)

2017

  1. Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs

    Molecular Diagnosis and Therapy, Vol. 21, Núm. 3, pp. 337-343

2016

  1. Circulating DNA and survival in solid tumors

    Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 2, pp. 399-406

  2. In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: Role of mitotic kinases

    Oncotarget, Vol. 7, Núm. 16, pp. 22865-22872

  3. Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer

    Breast Cancer Research and Treatment, Vol. 156, Núm. 1

2015

  1. Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: Systematic review and meta-analyses

    Oncotarget, Vol. 6, Núm. 37, pp. 39538-39549

2014

  1. Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: Systematic review and meta-analysis

    PLoS ONE, Vol. 9, Núm. 4

  2. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors

    Cancer and Metastasis Reviews, Vol. 33, Núm. 1, pp. 295-307

  3. Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis

    Cancer Treatment Reviews, Vol. 40, Núm. 9, pp. 1048-1055

2013

  1. HER3 overexpression and survival in solid tumors: A meta-analysis

    Journal of the National Cancer Institute, Vol. 105, Núm. 4, pp. 266-273

  2. The evolving landscape of protein kinases in breast cancer: Clinical implications

    Cancer Treatment Reviews, Vol. 39, Núm. 1, pp. 68-76

2011

  1. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs

    Journal of Clinical Oncology, Vol. 29, Núm. 18, pp. 2543-2549